MEDICAL DISCLAIMER:The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website.

Marfan Syndrome and Stroke

Learning objectives

  • Learning
  • Understand
  • Integrate
  • Reflect

  • Marfan syndrome is an autosomal dominant inherited disorder of the connective tissue
  • Incidence of around 1 in 9800 and 27% of cases arise from new mutation.
  • Weakness of the blood vessels, especially the aorta
  • Progressive dilatation of the aortic root leading to aortic regurgitation, dissection, or rupture
  • Possible association between Marfan syndrome and intracranial aneurysms
  • Classic triad of ocular, skeletal, and cardiovascular systems
  • Thin tall stature, pectus carinatum or excavatum, scoliosis
  • Joint hypermobility, arachnodactyly, pes planus
  • A high arched palate, and ectopia lentis
  • Aortic root dilation, usually maximal at the sinus of Valsalva
  • Associated with aortic valve incompetence
  • Mitral valve prolapse with incompetence may be significant
  • Assessment of family history, affected relatives Fibrillin 1 mutation testing if indicated
  • Transthoracic echo
  • Diagnosis by Ghent diagnostic nosology
  • Stroke is uncommon
  • Prophylactic aortic surgery should be considered when the aortic root at the Sinus of Valsalva exceeds 5cm